-+ 0.00%
-+ 0.00%
-+ 0.00%

HARMONI-GI1, A PHASE III TRIAL FEATURING IVONESCIMAB PLUS CHEMOTHERAPY COMPARED TO DURVALUMAB PLUS CHEMOTHERAPY IN FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED BILIARY TRACT CANCER FROM CHINA, TO BE SHOWCASED IN PRESIDENTIAL SYMPOSIUM AT ESMO 2026

路透·09/22/2026 10:00:00

请登录查看新闻详情